Clinical trial / 2004
Daily antioxidant, zinc, and copper supplementation showed no beneficial or harmful effect on cognition in older adults after nearly seven years.
Participants in the Age-Related Eye Disease Study were randomly assigned to receive daily antioxidants (500 mg vitamin C, 400 IU vitamin E, 15 mg beta carotene), zinc and copper (80 mg zinc, 2 mg cupric oxide), both, or placebo. A cognitive battery was administered to 2,166 elderly individuals after a median of 6.9 years of treatment. Treatment groups did not differ on any of the six cognitive tests (p > 0.05 for all), showing neither benefit nor harm on cognition.
- Study type
- Randomized controlled trial
- Who was studied
- 2,166 elderly participants in the Age-Related Eye Disease Study
- What was measured
- Performance on a cognitive battery (six cognitive tests)
THE PAPER
Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.
Yaffe K, Clemons TE, McBee WL, Lindblad AS, Age-Related Eye Disease Study Research Group. Neurology, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.